Drug Database
B01AC21 treprostinil
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Treposuvi 1 mg/ml solution for infusion
- POM Treposuvi 10 mg/ml solution for infusion
- POM Treposuvi 2.5 mg/ml solution for infusion
- POM Treposuvi 5 mg/ml solution for infusion
- POM Treprostinil 1 mg/ml Solution For Infusion
- POM Treprostinil 10 mg/ml Solution For Infusion
- POM Treprostinil 2.5 mg/ml Solution For Infusion
- POM Treprostinil 5 mg/ml Solution For Infusion
- POM Treprostinil Tillomed 1 mg/ml solution for infusion
- POM Treprostinil Tillomed 10 mg/ml solution for infusion
- POM Treprostinil Tillomed 2.5 mg/ml solution for infusion
- POM Treprostinil Tillomed 5 mg/ml solution for infusion
- POM Trepulmix 1 mg/ml solution for infusion
- POM Trepulmix 10 mg/ml solution for infusion
- POM Trepulmix 2.5 mg/ml solution for infusion
- POM Trepulmix 5 mg/ml solution for infusion
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).